The trial of a personal injury lawsuit filed against C.R. Bard (NYSE:BCR) ended in mistrial today after a federal judge granted Bard’s motion to dismiss, according to court documents.
Personal Injury
Hip implant lawsuits: DePuy moves to bar testimony of 2 experts from previous trial
Pelvic mesh lawsuits: Internal Bard memo shows medical device company knew mesh was unfit for humans
Endo Health’s American Medical Systems to settle mesh lawsuits for $55M
Endo Health Solutions (NSDQ:ENDP) subsidiary American Medical Systems said it’s agreed to pay $54 million to settle personal injury lawsuits filed over its pelvic mesh products.
Zimmer Holdings personal injury lawsuits sent back for reconsideration
Legal: Intuitive Surgical wins jury trial in da Vinci training claim
Intuitive Surgical (NSDQ:ISRG) won a legal victory in a patient injury lawsuit involving its da Vinci robotic surgical assist device.
DePuy Pinnacle lawsuits: Judge orders J&J’s DePuy Orthopaedics to produce compliance reports
Legal: Patient’s lawyer says Intuitive Surgical’s training is all about “control”
Legal: Intuitive Surgical witness says patient’s death was not robot-related
Robot-assisted surgical devices maker Intuitive Surgical (NSDQ:ISRG) defended its da Vinci technology during a liability lawsuit this week, questioning an expert witness who testified that the device wasn’t at fault for death of patient Fred Taylor.
Hips: Bellwether federal trial against DePuy delayed
The 1st trial representing a multi-district complaint against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics was delayed by court order, now slated to begin in June.
Update: Cook Medical recalls Zilver PTX delivery system following patient death
Updated April 25, 2013 with additional comments from Cook Medical.
Cook Medical recalled all sizes, diameters and lot numbers of its Zilver PTX drug-eluting stents after receiving reports of 1 death and 1 patient injury possibly associated with a breakage in the catheter delivery system. It’s not clear when the devices will be back on the market, according to a company spokesman.